Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Psychoneuroendocrinology|July 3, 2007
A single administration of cortisol acutely reduces preconscious attention for fear in anxious young menPeter Putman, Erno J Hermans, Hans Koppeschaar, et al.
Pharmacology, Biochemistry, and Behavior|February 19, 2014
Two novel combined drug treatments for women with hypoactive sexual desire disorderSaskia Poels, Jos Bloemers, Kim van Rooij, et al.
The Journal of Sexual Medicine|February 9, 2010
Induction of sexual arousal in women under conditions of institutional and ambulatory laboratory circumstances: a comparative studyJos Bloemers, Jeroen Gerritsen, Richard Bults, et al.
European Journal of Pharmacology|December 3, 2014
Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin (1A) receptor agonist in women with SSRI-induced sexual dysfunction. A preliminary studyKim van Rooij, Saskia Poels, Petra Worst, et al.
Psychoneuroendocrinology|June 5, 2004
Testosterone shifts the balance between sensitivity for punishment and reward in healthy young womenJack van Honk, Dennis J L G Schutter, Erno J Hermans, et al.
Psychoneuroendocrinology|October 11, 2011
Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal womenKim van Rooij, Jos Bloemers, Leo de Leede, et al.
Drugs in R&D|May 23, 2014
Pharmacokinetics of a prototype formulation of sublingual testosterone and a buspirone tablet, versus an advanced combination tablet of testosterone and buspirone in healthy premenopausal womenKim van Rooij, Leo de Leede, Henderik W Frijlink, et al.
The Journal of Sexual Medicine|February 12, 2009
The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunctionFlip van der Made, Jos Bloemers, Wadi E Yassem, et al.
The Journal of Sexual Medicine|November 8, 2012
Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorderJos Bloemers, Kim van Rooij, Saskia Poels, et al.
The Journal of Sexual Medicine|November 8, 2012
Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cuesSaskia Poels, Jos Bloemers, Kim van Rooij, et al.
Pageof 2